Five minutes with…Takanori Abe, Abe & Partners

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Five minutes with…Takanori Abe, Abe & Partners

Takanori.jpg

Each week Managing IP speaks to a different IP practitioner about their life and career

Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about IP practitioners on a personal as well as a professional level. This time we have Takanori Abe, managing partner at Abe & Partners in Osaka

Someone asks you at a party what you do for a living. What do you say?

I help protect “what is important but invisible”.

Talk us through a typical working day.

Morning: coffee accompanied by Mozart’s 'Requiem' by Herbert von Karajan.

Afternoon: tea with Bach’s 'Goldberg Variations' by Glenn Gould.

Night: red wine with Chopin's 'Piano Concerto No.1' by Nobuyuki Tsujii.

All the way through, I am thinking about how to win my cases. In my dreams, I talk with the judge.

What are you working on at the moment?

I am representing large global pharmaceutical companies across various pharma patent cases. This includes infringement cases between two originating companies, an originator and a biosimilar, and originators and generics. I am also managing invalidation and opposition proceedings at the JPO.

Meanwhile, I am also advising multinational and domestic clients on fair, reasonable, and non-discriminatory matters for standard-essential patents.

Does one big piece of work usually take priority or are you juggling multiple things?

I am required to multi-task like an astronaut.

What is the most exciting aspect of your role and what is the most stressful?

Seeing a client’s smiling face when we have won a case and shaking hands with them is the most exciting. Seeing their sad face when we have lost is the most stressful.

Tell us the key characteristics that make a successful IP lawyer/practitioner.

Eagerness to draw a new map.

What is the most common misconception about IP?

Criticism from bioethics that IP benefits only the wealthy.

What or who inspires you?

Susumu Tonegawa, the 1987 Nobel Prize winner for physiology or medicine. He clarified the genetic mechanism of the adaptive immune system, which had been the central question of immunology for more than 100 years.

If you weren't in IP, what would you be doing?

I’d like to be a molecular biologist.

Any advice you would give your younger self?

None.

more from across site and SHARED ros bottom lb

More from across our site

Tilleke & Gibbins topped the leaderboard with four awards across the region, while Anand & Anand and Kim & Chang emerged as outstanding domestic firms
News of a new addition to Via LA’s Qi wireless charging patent pool, and potential fee increases at the UKIPO were also among the top talking points
The keenly awaited ruling should act as a ‘call to arms’ for a much-needed evolution of UK copyright law, says Rebecca Newman at Addleshaw Goddard
Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Gift this article